Cargando…

Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing

BACKGROUND: The main commercially available methods for detecting small molecules of mycotoxins in traditional Chinese medicine (TCM) and functional foods are enzyme-linked immunosorbent assay and mass spectrometry. Regarding the development of diagnostic antibody reagents, effective methods for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yu-Ching, Lai, Gar-Hwa, Lin, Tsai-Yu, Tseng, Tien-Sheng, Tsai, Tsung-Hsun, Chen, Wang-Chuan, Lee, Cheng-Chung, Tsai, Keng-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127376/
https://www.ncbi.nlm.nih.gov/pubmed/37095503
http://dx.doi.org/10.1186/s13036-023-00350-y
_version_ 1785030452010024960
author Lee, Yu-Ching
Lai, Gar-Hwa
Lin, Tsai-Yu
Tseng, Tien-Sheng
Tsai, Tsung-Hsun
Chen, Wang-Chuan
Lee, Cheng-Chung
Tsai, Keng-Chang
author_facet Lee, Yu-Ching
Lai, Gar-Hwa
Lin, Tsai-Yu
Tseng, Tien-Sheng
Tsai, Tsung-Hsun
Chen, Wang-Chuan
Lee, Cheng-Chung
Tsai, Keng-Chang
author_sort Lee, Yu-Ching
collection PubMed
description BACKGROUND: The main commercially available methods for detecting small molecules of mycotoxins in traditional Chinese medicine (TCM) and functional foods are enzyme-linked immunosorbent assay and mass spectrometry. Regarding the development of diagnostic antibody reagents, effective methods for the rapid preparation of specific monoclonal antibodies are inadequate. METHODS: In this study, a novel synthetic phage-displayed nanobody Golden Glove (SynaGG) library with a glove-like cavity configuration was established using phage display technology in synthetic biology. We applied this unique SynaGG library on the small molecule aflatoxin B1 (AFB1), which has strong hepatotoxicity, to isolate specific nanobodies with high affinity for AFB1. RESULT: These nanobodies exhibit no cross-reactivity with the hapten methotrexate, which is recognized by the original antibody template. By binding to AFB1, two nanobodies can neutralize AFB1-induced hepatocyte growth inhibition. Using molecular docking, we found that the unique non-hypervariable complementarity-determining region 4 (CDR4) loop region of the nanobody was involved in the interaction with AFB1. Specifically, the CDR4’s positively charged amino acid arginine directed the binding interaction between the nanobody and AFB1. We then rationally optimized the interaction between AFB1 and the nanobody by mutating serine at position 2 into valine. The binding affinity of the nanobody to AFB1 was effectively improved, and this result supported the use of molecular structure simulation for antibody optimization. CONCLUSION: In summary, this study revealed that the novel SynaGG library, which was constructed through computer-aided design, can be used to isolate nanobodies that specifically bind to small molecules. The results of this study could facilitate the development of nanobody materials to detect small molecules for the rapid screening of TCM materials and foods in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13036-023-00350-y.
format Online
Article
Text
id pubmed-10127376
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101273762023-04-26 Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing Lee, Yu-Ching Lai, Gar-Hwa Lin, Tsai-Yu Tseng, Tien-Sheng Tsai, Tsung-Hsun Chen, Wang-Chuan Lee, Cheng-Chung Tsai, Keng-Chang J Biol Eng Research BACKGROUND: The main commercially available methods for detecting small molecules of mycotoxins in traditional Chinese medicine (TCM) and functional foods are enzyme-linked immunosorbent assay and mass spectrometry. Regarding the development of diagnostic antibody reagents, effective methods for the rapid preparation of specific monoclonal antibodies are inadequate. METHODS: In this study, a novel synthetic phage-displayed nanobody Golden Glove (SynaGG) library with a glove-like cavity configuration was established using phage display technology in synthetic biology. We applied this unique SynaGG library on the small molecule aflatoxin B1 (AFB1), which has strong hepatotoxicity, to isolate specific nanobodies with high affinity for AFB1. RESULT: These nanobodies exhibit no cross-reactivity with the hapten methotrexate, which is recognized by the original antibody template. By binding to AFB1, two nanobodies can neutralize AFB1-induced hepatocyte growth inhibition. Using molecular docking, we found that the unique non-hypervariable complementarity-determining region 4 (CDR4) loop region of the nanobody was involved in the interaction with AFB1. Specifically, the CDR4’s positively charged amino acid arginine directed the binding interaction between the nanobody and AFB1. We then rationally optimized the interaction between AFB1 and the nanobody by mutating serine at position 2 into valine. The binding affinity of the nanobody to AFB1 was effectively improved, and this result supported the use of molecular structure simulation for antibody optimization. CONCLUSION: In summary, this study revealed that the novel SynaGG library, which was constructed through computer-aided design, can be used to isolate nanobodies that specifically bind to small molecules. The results of this study could facilitate the development of nanobody materials to detect small molecules for the rapid screening of TCM materials and foods in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13036-023-00350-y. BioMed Central 2023-04-24 /pmc/articles/PMC10127376/ /pubmed/37095503 http://dx.doi.org/10.1186/s13036-023-00350-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lee, Yu-Ching
Lai, Gar-Hwa
Lin, Tsai-Yu
Tseng, Tien-Sheng
Tsai, Tsung-Hsun
Chen, Wang-Chuan
Lee, Cheng-Chung
Tsai, Keng-Chang
Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing
title Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing
title_full Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing
title_fullStr Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing
title_full_unstemmed Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing
title_short Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing
title_sort development of anti-aflatoxin b1 nanobodies from a novel mutagenesis-derived synthetic library for traditional chinese medicine and foods safety testing
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127376/
https://www.ncbi.nlm.nih.gov/pubmed/37095503
http://dx.doi.org/10.1186/s13036-023-00350-y
work_keys_str_mv AT leeyuching developmentofantiaflatoxinb1nanobodiesfromanovelmutagenesisderivedsyntheticlibraryfortraditionalchinesemedicineandfoodssafetytesting
AT laigarhwa developmentofantiaflatoxinb1nanobodiesfromanovelmutagenesisderivedsyntheticlibraryfortraditionalchinesemedicineandfoodssafetytesting
AT lintsaiyu developmentofantiaflatoxinb1nanobodiesfromanovelmutagenesisderivedsyntheticlibraryfortraditionalchinesemedicineandfoodssafetytesting
AT tsengtiensheng developmentofantiaflatoxinb1nanobodiesfromanovelmutagenesisderivedsyntheticlibraryfortraditionalchinesemedicineandfoodssafetytesting
AT tsaitsunghsun developmentofantiaflatoxinb1nanobodiesfromanovelmutagenesisderivedsyntheticlibraryfortraditionalchinesemedicineandfoodssafetytesting
AT chenwangchuan developmentofantiaflatoxinb1nanobodiesfromanovelmutagenesisderivedsyntheticlibraryfortraditionalchinesemedicineandfoodssafetytesting
AT leechengchung developmentofantiaflatoxinb1nanobodiesfromanovelmutagenesisderivedsyntheticlibraryfortraditionalchinesemedicineandfoodssafetytesting
AT tsaikengchang developmentofantiaflatoxinb1nanobodiesfromanovelmutagenesisderivedsyntheticlibraryfortraditionalchinesemedicineandfoodssafetytesting